Variant report
Variant | nsv820237 |
---|---|
Chromosome Location | chr8:69327804-69344263 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr8:69338439..69340713-chr8:69760510..69763451,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs117168348 | chr8:69327812-69327813 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs527728829 | chr8:69327842-69327843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs558985996 | chr8:69327862-69327863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs182306561 | chr8:69327883-69327884 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs76952191 | chr8:69327959-69327960 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs368621644 | chr8:69327977-69327978 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs548782751 | chr8:69327980-69327981 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs113940374 | chr8:69327993-69327994 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs372651508 | chr8:69328008-69328009 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs551694305 | chr8:69328059-69328060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs571410038 | chr8:69328085-69328086 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs185496059 | chr8:69328088-69328089 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs553459523 | chr8:69328141-69328142 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs140072624 | chr8:69328154-69328155 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
15 | rs536384846 | chr8:69328194-69328195 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
16 | rs72664940 | chr8:69328200-69328201 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs576760018 | chr8:69328204-69328205 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs190184595 | chr8:69328212-69328213 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
19 | rs565583874 | chr8:69328213-69328214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs572606028 | chr8:69328257-69328258 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541437917 | chr8:69328299-69328300 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs560912976 | chr8:69328317-69328318 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs530022372 | chr8:69328394-69328395 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs143707230 | chr8:69328435-69328436 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs115839944 | chr8:69328491-69328492 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs367657686 | chr8:69328502-69328503 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
27 | rs182780266 | chr8:69328509-69328510 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
28 | rs369373205 | chr8:69328564-69328565 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
29 | rs574465816 | chr8:69328584-69328585 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
30 | rs371768186 | chr8:69328676-69328677 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
31 | rs551239375 | chr8:69328687-69328688 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
32 | rs570243866 | chr8:69328716-69328717 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
33 | rs114481691 | chr8:69328737-69328738 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
34 | rs533810393 | chr8:69328739-69328740 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
35 | rs35528191 | chr8:69328747-69328748 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
36 | rs555758382 | chr8:69328748-69328749 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
37 | rs542111042 | chr8:69328752-69328753 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs144248592 | chr8:69328755-69328756 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs147768404 | chr8:69328774-69328775 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs398008208 | chr8:69328784-69328785 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs188553189 | chr8:69328789-69328790 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs111573347 | chr8:69328829-69328830 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs192936826 | chr8:69328862-69328863 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs536247932 | chr8:69328912-69328913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs142956678 | chr8:69328975-69328976 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs183900768 | chr8:69329001-69329002 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs539227324 | chr8:69329002-69329003 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs34225325 | chr8:69329033-69329034 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
49 | rs12550291 | chr8:69329034-69329035 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs78536627 | chr8:69329059-69329060 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Gastric cancer | 17908304 | CNVD |
Melanoma | 18172304 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Autism | 19415332 | CNVD |
Malaria | 21533027 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Breast cancer | 21245420 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Liver carcinoma | 19366792 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Seminomas | 18059402 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Pancreatic cancer | 21811587 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Breast cancer | 17603634 | CNVD |
Testicular cancer | 18059402 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 17133270 | CNVD |
Breast cancer | 21509527 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 21248843 | CNVD |
Cancer | 20164919 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Multiple myeloma | 16461302 | CNVD |
abnormal development | 18461090 | CNVD |
Cancer | 20164920 | CNVD |
Oral cancer | 21386901 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Langer-Giedion syndrome | 22283845 | CNVD |
Cancer | 21637783 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 20632083 | CNVD |
Breast cancer | 19602461 | CNVD |
Cancer | 22429812 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Oral cancer | 19627613 | CNVD |
Prostate cancer | 21088497 | CNVD |
colon cancer | 17210682 | CNVD |
Breast cancer | 21264507 | CNVD |
Breast cancer | 22028636 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 16751803 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Gastric cancer | 17167181 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Breast cancer | 16461572 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Medulloblastoma | 16968546 | CNVD |
head and neck squamous cell carcinoma | 18028549 | CNVD |
Breast cancer | 17001317 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Lung cancer | 18438408 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 16608533 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Hepatocellular carcinoma | 18803288 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 18628472 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Prostate cancer | 16573809 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Melanoma | 22183965 | CNVD |
Cancer | 21949371 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Acute myeloid leukemia | 21358987 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
Sezary syndrome | 18413736 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
head and neck squamous cell carcinoma | 16715129 | CNVD |
Prostate cancer | 16461572 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Breast cancer | 21399628 | CNVD |
Acute lymphoblastic leukemia | 18458336 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr8:69317200-69342600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
2 | chr8:69325200-69332400 | Weak transcription | Aorta | Aorta |
3 | chr8:69332400-69332600 | Enhancers | Aorta | Aorta |
4 | chr8:69332600-69333000 | Enhancers | Primary monocytes fromperipheralblood | blood |
5 | chr8:69332600-69333800 | Enhancers | Monocytes-CD14+_RO01746 | blood |
6 | chr8:69332600-69334000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
7 | chr8:69332600-69334200 | Weak transcription | Aorta | Aorta |
8 | chr8:69333000-69333400 | Weak transcription | Primary monocytes fromperipheralblood | blood |
9 | chr8:69333000-69334000 | Enhancers | Muscle Satellite Cultured Cells | -- |
10 | chr8:69333000-69334000 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
11 | chr8:69333000-69334000 | Enhancers | HUVEC | blood vessel |
12 | chr8:69333000-69334000 | Enhancers | NHEK | skin |
13 | chr8:69333200-69333600 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
14 | chr8:69333200-69333800 | Enhancers | NH-A | brain |
15 | chr8:69333400-69334200 | Enhancers | Primary monocytes fromperipheralblood | blood |
16 | chr8:69333400-69334200 | Enhancers | HMEC | breast |
17 | chr8:69333600-69334200 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
18 | chr8:69334200-69334400 | Enhancers | Aorta | Aorta |
19 | chr8:69334400-69335000 | Weak transcription | Aorta | Aorta |
20 | chr8:69340800-69341600 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
21 | chr8:69341600-69342200 | Flanking Active TSS | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
22 | chr8:69342200-69343800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
23 | chr8:69342600-69343000 | Enhancers | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
24 | chr8:69342800-69364800 | Weak transcription | Aorta | Aorta |
25 | chr8:69343000-69345600 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |